Correlation Between Diffusion Pharmaceuticals and Onconova Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Onconova Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Onconova Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Onconova Therapeutics, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Onconova Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Onconova Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Onconova Therapeutics.

Diversification Opportunities for Diffusion Pharmaceuticals and Onconova Therapeutics

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Diffusion and Onconova is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Onconova Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onconova Therapeutics and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Onconova Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onconova Therapeutics has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Onconova Therapeutics go up and down completely randomly.

Pair Corralation between Diffusion Pharmaceuticals and Onconova Therapeutics

Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to generate 0.72 times more return on investment than Onconova Therapeutics. However, Diffusion Pharmaceuticals is 1.39 times less risky than Onconova Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Onconova Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  380.00  in Diffusion Pharmaceuticals on August 26, 2024 and sell it today you would lose (53.00) from holding Diffusion Pharmaceuticals or give up 13.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Diffusion Pharmaceuticals  vs.  Onconova Therapeutics

 Performance 
       Timeline  
Diffusion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diffusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Diffusion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Onconova Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconova Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Onconova Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Diffusion Pharmaceuticals and Onconova Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diffusion Pharmaceuticals and Onconova Therapeutics

The main advantage of trading using opposite Diffusion Pharmaceuticals and Onconova Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Onconova Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconova Therapeutics will offset losses from the drop in Onconova Therapeutics' long position.
The idea behind Diffusion Pharmaceuticals and Onconova Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing